Levy, Kenneth D.
Wu, R. Ryanne
Goto, Daisuke
Ramos, Michelle A.
Pratt, Victoria M.
Hicks, J. Kevin
Madden, Ebony B.
Bell, Gillian C.
Blake, Kathryn V.
Cohen, Michelle
Duong, Benjamin Q.
Franciosi, James P.
Orlando, Lori A.
Sanghavi, Kunal
Ginsburg, Geoffrey S.
Funding for this research was provided by:
National Human Genome Research Institute (5U01HG007762-04, 3U01HG007762-04S2, 1U01HG007282-01, 3U01-HG007282)
Article History
Received: 9 October 2019
Accepted: 17 March 2020
First Online: 29 April 2020
Ethics approval and consent to participate
: This article does not contain patient personal health information nor does it reference individual study site human research results.
: Not applicable.
: Daisuke Goto is employed by Merck Sharp & Corp. and shareholder, Merck & Co. Inc. Vicky Pratt is the Director of the IU School of Medicine Pharmacogenomics Laboratory that also serves as a fee-for-service clinical reference laboratory. J. Kevin Hicks is a paid academic associate for Quest Diagnostics and receives funding from OneOme Inc.; all other contributing authors declare that they have no competing interests.